cancers-logo

Journal Browser

Journal Browser

Cancer Cell Metabolism in Tumor Microenvironment

A Special Issue of Cancers (ISSN 2072-6694) belonging to the section "Molecular Cancer Biology".

Deadline for manuscript submissions: 31 March 2027 | Viewed by 215

Editor


E-Mail Website
Guest Editor
Amity Institute of Biotechnology, Amity University, Kolkata, Plot IIA-36, 37 & 38, Action Area II, Kolkata 700156, West Bengal, India
Interests: cell culture; metabolism; cell biology; biotechnology; apoptosis; cancer biology

Special Issue Information

Dear Colleagues,

Tumour microenvironments (TMEs) devoid of nutrients allow cancer cells to adapt and survive through metabolic reprogramming and plasticity. Tumour bioenergetics rely heavily on intricate cellular crosstalk, lactic acidosis (the Warburg effect), and hypoxia adaptation. By actively scavenging alternative nutrients like glutamine & specific lipids, reprogrammed cancer cells evade immune surveillance and acquire resistance to therapeutic targeting. Overcoming these challenges requires utilizing cutting-edge single-cell analysis, multi-omics integration, and spatial detection technologies. Furthermore, the development of accurate individualized metabolic therapies relies on dynamic tracking and visualization of these metabolic rewiring processes over time. This Special Issue highlights the complex interactions within the TME and explores new therapeutic approaches intended to address these metabolic vulnerabilities.

We look forward to receiving your contributions.

Dr. Mukherjee Tapan Kumar
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • tumour microenvironments (TMEs)
  • metabolic reprogramming
  • tumour bioenergetics
  • hypoxia adaptation
  • immune surveillance
  • therapeutic resistance
  • multi-omics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop